Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.64 (
MPP
)
1,876
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Heat shock proteins (HSPs) play an essential role in various neurodegenerative diseases. Manipulation of upregulation of HSPs in cells has been demonstrated to provide a therapeutic strategy to counteract the misfolding and aggregation of proteins that resulted in neurodegenerative disease. Our previous studies have shown that FLZ, a synthetic novel derivative of squamosamide from a Chinese herb, had potent neuroprotective effect against several experimental Parkinson's disease (PD) models. However, the mechanism of its neuroprotective effect is still not clarified. The present study demonstrated that FLZ induced
HSP27
and HSP70 proteins and mRNA expression in a time- and dose-dependent manner in SH-SY5Y cells. Further studies showed that FLZ treatment stimulated the activation of heat shock factor 1 (HSF1) and its regulatory kinase Akt. Inactivation of Akt pathway by the PI3K inhibitor LY294002 blocked the expression of
HSP27
and HSP70 induced by FLZ. Moreover, the inducing effects of FLZ on
HSP27
, HSP70, and HSF1 were all blocked by quercetin, an inhibitor of HSP biosynthesis. The cytoprotective effect of
HSP27
/HSP70 induced by FLZ against
MPP
(+) was assessed in SH-SY5Y cells. The pretreatment of FLZ significantly induced the accumulations of
HSP27
/HSP70 and suppressed the apoptosis caused by
MPP
(+) in SH-SY5Y cells. However, the protective effects of FLZ against
MPP
(+) were significantly blocked by quercetin, which indicated that the cytoprotective action of FLZ against
MPP
(+)-induced apoptosis is at least partially mediated by its induction of
HSP27
/HSP70. These results provide new evidence for elucidating the mechanism of the neuroprotective effect of FLZ against PD.
...
PMID:FLZ, a novel HSP27 and HSP70 inducer, protects SH-SY5Y cells from apoptosis caused by MPP(+). 3276 97
Heat shock proteins (HSPs) are a highly conserved family of proteins that are induced in response to various environmental stressors including reactive oxygen species.
HSP27
is a chaperone protein with the ability to increase cell survival in response to oxidative stress. Parkinson's disease (PD) is a neurodegenerative disorder characterized by loss of dopaminergic neurons. Although the mechanism of PD remains unclear, oxidative stress is known to be important in its pathogenesis. This study investigated the protective effects of PEP-1-
HSP27
on neuronal damage induced by 1-methyl-4-phenyl pyridinium (
MPP
(+) ) in SH-SY5Y cells and in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mouse model. PEP-1-
HSP27
rapidly entered the cells and protected them against
MPP
(+) -induced toxicity by inhibiting the reactive oxygen species levels and DNA fragmentation. Furthermore, transduced PEP-1-
HSP27
prevented dopaminergic neuronal cell death in the substantia nigra of MPTP-induced PD mouse models. These results demonstrate that PEP-1-
HSP27
provides a potential strategy for therapeutic delivery against various diseases and is a potential tool for the treatment of PD.
...
PMID:PEP-1-heat shock protein 27 protects from neuronal damage in cells and in a Parkinson's disease mouse model. 2242 28